Q
Qiang Shen
Researcher at LSU Health Sciences Center New Orleans
Publications - 91
Citations - 4304
Qiang Shen is an academic researcher from LSU Health Sciences Center New Orleans. The author has contributed to research in topics: Cancer & Breast cancer. The author has an hindex of 37, co-authored 80 publications receiving 3318 citations. Previous affiliations of Qiang Shen include University of Texas Medical Branch & University of Texas MD Anderson Cancer Center.
Papers
More filters
Journal ArticleDOI
Cancer drug delivery in the nano era: An overview and perspectives (Review)
TL;DR: The development of nanomaterial drug carriers, including liposomes, polymer nanoparticles, dendritic polymers, and nanomicelles, for the diagnosis and treatment of various cancers are reviewed.
Journal ArticleDOI
Transcription Factor STAT3 as a Novel Molecular Target for Cancer Prevention
TL;DR: Current literature is summarized, the potential importance of STAT3 as a novel target for cancer prevention and ofSTAT3 inhibitors as effective chemopreventive agents are discussed and the lag in developing effective STAT3 inhibitors is summarized.
Journal ArticleDOI
The role of STAT3 in leading the crosstalk between human cancers and the immune system
TL;DR: Accumulating evidence suggests that targeting STAT3 may enhance anti-cancer immune responses and rescue the suppressed immunologic microenvironment in tumors.
Journal ArticleDOI
Small molecule inhibitors targeting activator protein 1 (AP-1).
TL;DR: AP-1 is a pivotal transcription factor that regulates a wide range of cellular processes including proliferation, apoptosis, differentiation, survival, cell migration, and transformation, and it has emerged as an actively pursued drug discovery target over the past decade as discussed by the authors.
Journal ArticleDOI
TRPM7 mediates breast cancer cell migration and invasion through the MAPK pathway
Xiaojing Meng,Chunqing Cai,Jiguo Wu,Shaoxi Cai,Changsheng Ye,Haiyang Chen,Zhengduo Yang,Hongqiang Zeng,Qiang Shen,Fei Zou +9 more
TL;DR: The results suggest that TRPM7 regulates migration and invasion of metastatic breast cancer cells via MAPK pathway.